RESEARCH
[Publication] Mammalian Tolerance to Amino Acid Heterochirality
July 22, 2025
Organisms preferentially use l-amino acids (l-AAs). However, de novo synthesized l-AAs are in part converted to d-AAs. The ribosome has a robust system to use l-AAs for protein synthesis, whereas non-ribosomal synthesis can also use d-AAs. Furthermor
Credits: 2025 Sakiko Taniguchi et al.
Co-authored by Bio2Q and Keio University researchers, this Review explores the role of D-amino acids in mammals, highlighting their functional relevance despite the body’s predominant use of L-enantiomers. The authors outline how enzymatic control, microbial interactions, and tissue-level adaptations allow mammals to maintain control over environments with mixed amino acid chirality.
| Title | Mammalian Tolerance to Amino Acid Heterochirality |
|---|---|
| Authors | Sakiko Taniguchi [1],[2], Kenichiro Adachi [1], Xuan Tran [1],[3], Masataka Suzuki [1],[4], Jumpei Sasabe [5],[6], |
| Short Description | This review article, co-authored by Bio2Q and Keio University researchers, examines how mammals tolerate and utilize D-amino acids, once thought to be inert or even harmful byproducts of metabolism. While systemic amino acid metabolism strongly favors L-enantiomers, this work highlights the active roles that D-amino acids play in the brain, endocrine system, immune signaling, and in the gut epithelium. The authors integrate findings from across disciplines, including microbiome science, to explore how enzymatic degradation, renal filtration, and cellular proofreading mechanisms coordinate to maintain overall homochirality, while also supporting functional heterochirality. This Review works to reframe D-amino acids not as metabolic errors, but as selectively integrated components of mammalian physiology, offering a foundation for future research into their regulatory and therapeutic potential. |
| DOI | https://doi.org/10.1016/j.coi.2025.102568. |
| Journal | ChemBioChem |
| Vol/Num/Page | Volume 26, Issue 13, e202500273 |
| Publication Date | 2025 June 3. |
Affiliations:
[1] Department of Pharmacology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
[2] Research Fellow of Japan Society for the Promotion of Science, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
[3] Department of Plant Physiology, Eberhard Karls Universitat Tubingen, Auf der Morgenstalle 32, 72076 Tubingen, Germany
[4] Department of Medicine, Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115 USA
[5] Laboratory of Electron Microscope and Chiral Medical Biology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
[6] WPI-Bio2Q, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan
SHARE
More Bio2Q News
【Seminar】 WPI-Bio2Q Open Seminar: Tomoe Ishikawa, Ph.D.（for Keio Members）
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty...
OPEN CALL: Technical Staff (Animal Experiments)
The Bio2Q Open Lab invites applications for a proactive, highly organized, and safety-conscious lab technician with hands-on experience in a...
WPI-Bio2Q Social Event (2025.12.19)
WPI-Bio2Q held a social event at Keio University’s Shinanomachi Campus. Date & Time: Friday, December 19, 2025 Venue: Bio2Q Open Lab...
Research Internship Program 2026（Period 2)
Bio2Q is now offering a research internship opportunity as part of STaMP, a joint cross-disciplinary graduate English program for students i...
【1/7 Seminar】WPI-Bio2Q Open Seminar: Masahiro Kanai, PhD
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty...
